Literature DB >> 15489566

Mitochondrial injury in steatohepatitis.

Dominique Pessayre1, Bernard Fromenty, Abdellah Mansouri.   

Abstract

Rich diet and lack of exercise are causing a surge in obesity, insulin resistance and steatosis, which can evolve into steatohepatitis. Patients with non-alcoholic steatohepatitis have increased lipid peroxidation, increased tumour necrosis factor-alpha (TNF-alpha) and increased mitochondrial beta-oxidation rates. Their in-vivo ability to re-synthesize ATP after a fructose challenge is decreased, and their hepatic mitochondria exhibit ultrastructural lesions, depletion of mitochondrial DNA and decreased activity of respiratory chain complexes. Although the mechanisms for these effects is unknown, the basal cellular formation of reactive oxygen species (ROS) may oxidize fat deposits to cause lipid peroxidation, which damages mitochondrial DNA, proteins and cardiolipin to partially hamper the flow of electrons within the respiratory chain. This flow may be further decreased by TNF-alpha, which can release cytochrome c from mitochondria. Concomitantly, the increased mitochondrial fatty acid beta-oxidation rate augments the delivery of electrons to the respiratory chain. Due to the imbalance between a high electron input and a restricted outflow, electrons may accumulate within complexes I and III, and react with oxygen to form the superoxide anion radical. Increased mitochondrial ROS formation could in turn directly oxidize mitochondrial DNA, proteins and lipids, enhance lipid peroxidation-related mitochondrial damage, trigger hepatic TNF-alpha formation and deplete antioxidants, thus further blocking electron flow and further increasing mitochondrial ROS formation. Mitochondrial dysfunction plays an important role in liver lesions, through the ROS-induced release of both biologically active lipid peroxidation products and cytokines. In particular, the up-regulation of both TNF-alpha and Fas triggers mitochondrial membrane permeability and apoptosis. The ingestion of apoptotic bodies by stellate cells stimulates fibrogenesis, which is further activated by lipid peroxidation products and high leptin levels. Chronic apoptosis is compensated by increased cell proliferation, which, together with oxidative DNA damage, may cause gene mutations and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489566     DOI: 10.1097/00042737-200411000-00003

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  39 in total

1.  Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.

Authors:  Yu-Cheng Lin; Shu-Tin Hsiao; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 2.  Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations.

Authors:  Aurélia De Pauw; Silvia Tejerina; Martine Raes; Jaap Keijer; Thierry Arnould
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 3.  Impact of high dietary lipid intake and related metabolic disorders on the abundance and acyl composition of the unique mitochondrial phospholipid, cardiolipin.

Authors:  Christine Feillet-Coudray; Gilles Fouret; François Casas; Charles Coudray
Journal:  J Bioenerg Biomembr       Date:  2014-06-21       Impact factor: 2.945

Review 4.  Mitochondrial fitness and insulin sensitivity in humans.

Authors:  J Szendroedi; M Roden
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

Review 5.  A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.

Authors:  Raffaella Crescenzo; Francesca Bianco; Arianna Mazzoli; Antonia Giacco; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2016-02       Impact factor: 5.614

Review 6.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

7.  Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.

Authors:  Ying Chen; Elisabet Johansson; Yi Yang; Marian L Miller; Dongxiao Shen; David J Orlicky; Howard G Shertzer; Vasilis Vasiliou; Daniel W Nebert; Timothy P Dalton
Journal:  J Hepatol       Date:  2010-08-11       Impact factor: 25.083

Review 8.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

Review 9.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

10.  Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways.

Authors:  Joy X Jiang; Kenichiro Mikami; Senthil Venugopal; Yong Li; Natalie J Török
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.